

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.35243664 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.35243664 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.03405336 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.03405336 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.51159664 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.46513691 |
| 7 | tryptophan catabolic process (GO:0006569) | 5.74041256 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 5.74041256 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 5.74041256 |
| 10 | high-density lipoprotein particle remodeling (GO:0034375) | 5.69075033 |
| 11 | bile acid biosynthetic process (GO:0006699) | 5.63814283 |
| 12 | kynurenine metabolic process (GO:0070189) | 5.62579010 |
| 13 | alpha-linolenic acid metabolic process (GO:0036109) | 5.62492251 |
| 14 | glyoxylate metabolic process (GO:0046487) | 5.62481197 |
| 15 | negative regulation of fibrinolysis (GO:0051918) | 5.62016306 |
| 16 | urea cycle (GO:0000050) | 5.57391046 |
| 17 | urea metabolic process (GO:0019627) | 5.57391046 |
| 18 | detection of molecule of bacterial origin (GO:0032490) | 5.55608180 |
| 19 | positive regulation by symbiont of host defense response (GO:0052509) | 5.49438143 |
| 20 | modulation by symbiont of host defense response (GO:0052031) | 5.49438143 |
| 21 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.49438143 |
| 22 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.49438143 |
| 23 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.49438143 |
| 24 | modulation by symbiont of host immune response (GO:0052553) | 5.49438143 |
| 25 | tryptophan metabolic process (GO:0006568) | 5.44319761 |
| 26 | regulation of fibrinolysis (GO:0051917) | 5.39016697 |
| 27 | sulfur amino acid catabolic process (GO:0000098) | 5.34371953 |
| 28 | protein carboxylation (GO:0018214) | 5.32950050 |
| 29 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.32950050 |
| 30 | complement activation, alternative pathway (GO:0006957) | 5.28659139 |
| 31 | cysteine metabolic process (GO:0006534) | 5.15961376 |
| 32 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.14611105 |
| 33 | regulation of protein activation cascade (GO:2000257) | 5.12987160 |
| 34 | nitrogen cycle metabolic process (GO:0071941) | 5.11942385 |
| 35 | regulation of cholesterol esterification (GO:0010872) | 5.09893125 |
| 36 | reverse cholesterol transport (GO:0043691) | 5.01945344 |
| 37 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.99076602 |
| 38 | regulation of triglyceride catabolic process (GO:0010896) | 4.98707538 |
| 39 | plasma lipoprotein particle remodeling (GO:0034369) | 4.93477294 |
| 40 | protein-lipid complex remodeling (GO:0034368) | 4.93477294 |
| 41 | macromolecular complex remodeling (GO:0034367) | 4.93477294 |
| 42 | serine family amino acid catabolic process (GO:0009071) | 4.90980250 |
| 43 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.88614790 |
| 44 | bile acid metabolic process (GO:0008206) | 4.88463747 |
| 45 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.78501854 |
| 46 | tyrosine metabolic process (GO:0006570) | 4.77878847 |
| 47 | regulation of complement activation (GO:0030449) | 4.76786498 |
| 48 | negative regulation of cell killing (GO:0031342) | 4.76655746 |
| 49 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.76655746 |
| 50 | aromatic amino acid family metabolic process (GO:0009072) | 4.73218661 |
| 51 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.71482445 |
| 52 | phospholipid efflux (GO:0033700) | 4.70958527 |
| 53 | microglial cell activation (GO:0001774) | 4.70675736 |
| 54 | plasma lipoprotein particle clearance (GO:0034381) | 4.69301708 |
| 55 | homocysteine metabolic process (GO:0050667) | 4.67106516 |
| 56 | macrophage activation involved in immune response (GO:0002281) | 4.66758302 |
| 57 | triglyceride homeostasis (GO:0070328) | 4.60284350 |
| 58 | acylglycerol homeostasis (GO:0055090) | 4.60284350 |
| 59 | amino-acid betaine metabolic process (GO:0006577) | 4.59279750 |
| 60 | cellular extravasation (GO:0045123) | 4.53147737 |
| 61 | negative regulation of sterol transport (GO:0032372) | 4.49334671 |
| 62 | negative regulation of cholesterol transport (GO:0032375) | 4.49334671 |
| 63 | alpha-amino acid catabolic process (GO:1901606) | 4.45098743 |
| 64 | neutrophil activation involved in immune response (GO:0002283) | 4.43480579 |
| 65 | neutrophil mediated immunity (GO:0002446) | 4.35434432 |
| 66 | cellular ketone body metabolic process (GO:0046950) | 4.34419026 |
| 67 | cholesterol efflux (GO:0033344) | 4.31781310 |
| 68 | detection of external biotic stimulus (GO:0098581) | 4.28357615 |
| 69 | lysine metabolic process (GO:0006553) | 4.26641626 |
| 70 | lysine catabolic process (GO:0006554) | 4.26641626 |
| 71 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.24479821 |
| 72 | bile acid and bile salt transport (GO:0015721) | 4.15479200 |
| 73 | plasma lipoprotein particle assembly (GO:0034377) | 4.15222370 |
| 74 | macrophage activation (GO:0042116) | 4.11335564 |
| 75 | detection of other organism (GO:0098543) | 4.10590088 |
| 76 | cellular amino acid catabolic process (GO:0009063) | 4.09865648 |
| 77 | glycine metabolic process (GO:0006544) | 4.09658272 |
| 78 | low-density lipoprotein particle remodeling (GO:0034374) | 4.09323594 |
| 79 | imidazole-containing compound metabolic process (GO:0052803) | 4.08556196 |
| 80 | indolalkylamine metabolic process (GO:0006586) | 4.06959907 |
| 81 | coenzyme catabolic process (GO:0009109) | 4.05907024 |
| 82 | aldehyde catabolic process (GO:0046185) | 4.03377812 |
| 83 | fibrinolysis (GO:0042730) | 4.02528530 |
| 84 | neutrophil activation (GO:0042119) | 4.01517218 |
| 85 | glutamate metabolic process (GO:0006536) | 4.01223303 |
| 86 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.00269361 |
| 87 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.99591658 |
| 88 | positive regulation of lipid catabolic process (GO:0050996) | 3.99526667 |
| 89 | cellular biogenic amine catabolic process (GO:0042402) | 3.99296005 |
| 90 | amine catabolic process (GO:0009310) | 3.99296005 |
| 91 | drug catabolic process (GO:0042737) | 3.99197314 |
| 92 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.98356285 |
| 93 | arginine metabolic process (GO:0006525) | 3.97419111 |
| 94 | benzene-containing compound metabolic process (GO:0042537) | 3.96223757 |
| 95 | negative regulation of lipase activity (GO:0060192) | 3.94223399 |
| 96 | cellular glucuronidation (GO:0052695) | 3.94214197 |
| 97 | cellular modified amino acid catabolic process (GO:0042219) | 3.90314024 |
| 98 | serine family amino acid metabolic process (GO:0009069) | 3.89241059 |
| 99 | ethanol oxidation (GO:0006069) | 3.89098568 |
| 100 | response to host immune response (GO:0052572) | 3.88295610 |
| 101 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.88295610 |
| 102 | blood coagulation, intrinsic pathway (GO:0007597) | 3.87359782 |
| 103 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.87052188 |
| 104 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.87052188 |
| 105 | response to peptidoglycan (GO:0032494) | 3.85124848 |
| 106 | regulation of gamma-delta T cell activation (GO:0046643) | 3.84428661 |
| 107 | negative regulation of B cell mediated immunity (GO:0002713) | 3.82789520 |
| 108 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 3.82789520 |
| 109 | phospholipid homeostasis (GO:0055091) | 3.81625534 |
| 110 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.81264557 |
| 111 | plasma lipoprotein particle organization (GO:0071827) | 3.78360812 |
| 112 | negative regulation of interleukin-12 production (GO:0032695) | 3.76877726 |
| 113 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.76779684 |
| 114 | cholesterol homeostasis (GO:0042632) | 3.76612359 |
| 115 | ketone body metabolic process (GO:1902224) | 3.75102352 |
| 116 | detection of biotic stimulus (GO:0009595) | 3.74439810 |
| 117 | cofactor catabolic process (GO:0051187) | 3.71958576 |
| 118 | protein-lipid complex assembly (GO:0065005) | 3.71728033 |
| 119 | acute-phase response (GO:0006953) | 3.70756858 |
| 120 | sterol homeostasis (GO:0055092) | 3.70432817 |
| 121 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.70215089 |
| 122 | protein activation cascade (GO:0072376) | 3.69011584 |
| 123 | serine family amino acid biosynthetic process (GO:0009070) | 3.68054240 |
| 124 | myeloid leukocyte mediated immunity (GO:0002444) | 3.65384535 |
| 125 | complement activation (GO:0006956) | 3.65355371 |
| 126 | carboxylic acid catabolic process (GO:0046395) | 3.65114415 |
| 127 | organic acid catabolic process (GO:0016054) | 3.65114415 |
| 128 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.64672632 |
| 129 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.64436453 |
| 130 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.61140512 |
| 131 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.60007224 |
| 132 | epoxygenase P450 pathway (GO:0019373) | 3.58957823 |
| 133 | opsonization (GO:0008228) | 3.58272856 |
| 134 | complement activation, classical pathway (GO:0006958) | 3.56764527 |
| 135 | protein-lipid complex subunit organization (GO:0071825) | 3.55484200 |
| 136 | short-chain fatty acid metabolic process (GO:0046459) | 3.55232152 |
| 137 | acetyl-CoA metabolic process (GO:0006084) | 3.53506502 |
| 138 | glucuronate metabolic process (GO:0019585) | 3.52904814 |
| 139 | uronic acid metabolic process (GO:0006063) | 3.52904814 |
| 140 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.51523627 |
| 141 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.49812142 |
| 142 | granulocyte activation (GO:0036230) | 3.49805515 |
| 143 | response to interleukin-15 (GO:0070672) | 3.48029729 |
| 144 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.47439251 |
| 145 | detection of bacterium (GO:0016045) | 3.46004561 |
| 146 | response to host (GO:0075136) | 3.40860382 |
| 147 | response to host defenses (GO:0052200) | 3.40860382 |
| 148 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.40860382 |
| 149 | cellular response to interleukin-15 (GO:0071350) | 3.40051921 |
| 150 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.38324318 |
| 151 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.37877098 |
| 152 | respiratory burst (GO:0045730) | 3.36925352 |
| 153 | myeloid cell activation involved in immune response (GO:0002275) | 3.36218976 |
| 154 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.29608759 |
| 155 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.20123207 |
| 156 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.16661123 |
| 157 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 3.14997734 |
| 158 | negative regulation of T cell mediated immunity (GO:0002710) | 3.14210249 |
| 159 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.12001255 |
| 160 | positive regulation of mast cell activation (GO:0033005) | 3.11979213 |
| 161 | regulation of mast cell activation (GO:0033003) | 3.11508734 |
| 162 | neural tube formation (GO:0001841) | 3.10203679 |
| 163 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.08188303 |
| 164 | leukocyte aggregation (GO:0070486) | 3.07549231 |
| 165 | B cell receptor signaling pathway (GO:0050853) | 3.07475139 |
| 166 | positive regulation of interferon-alpha production (GO:0032727) | 3.05549913 |
| 167 | regulation of germinal center formation (GO:0002634) | 3.05001560 |
| 168 | negative regulation of adaptive immune response (GO:0002820) | 3.03082162 |
| 169 | superoxide anion generation (GO:0042554) | 3.02795799 |
| 170 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.97948245 |
| 171 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.97948245 |
| 172 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.95999670 |
| 173 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.95212135 |
| 174 | defense response to protozoan (GO:0042832) | 2.93897503 |
| 175 | immunoglobulin mediated immune response (GO:0016064) | 2.92006224 |
| 176 | regulation of interferon-alpha production (GO:0032647) | 2.89544571 |
| 177 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.85413799 |
| 178 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.84181832 |
| 179 | interferon-gamma production (GO:0032609) | 2.80623102 |
| 180 | regulation of mast cell degranulation (GO:0043304) | 2.79715615 |
| 181 | regulation of memory T cell differentiation (GO:0043380) | 2.79149559 |
| 182 | negative regulation of humoral immune response (GO:0002921) | 2.77707229 |
| 183 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.76813234 |
| 184 | activated T cell proliferation (GO:0050798) | 2.76037492 |
| 185 | germinal center formation (GO:0002467) | 2.74345671 |
| 186 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.73641417 |
| 187 | response to type I interferon (GO:0034340) | 2.73289601 |
| 188 | negative regulation of interleukin-1 production (GO:0032692) | 2.72008747 |
| 189 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.71742183 |
| 190 | cellular response to type I interferon (GO:0071357) | 2.70363591 |
| 191 | type I interferon signaling pathway (GO:0060337) | 2.70363591 |
| 192 | dendritic cell migration (GO:0036336) | 2.67995230 |
| 193 | tolerance induction (GO:0002507) | 2.67890275 |
| 194 | neutrophil chemotaxis (GO:0030593) | 2.64975686 |
| 195 | positive regulation of interferon-beta production (GO:0032728) | 2.64384078 |
| 196 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.63973224 |
| 197 | positive regulation of mast cell degranulation (GO:0043306) | 2.63973224 |
| 198 | regulation of tolerance induction (GO:0002643) | 2.63087081 |
| 199 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.62793981 |
| 200 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.62269858 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.17204908 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.97442548 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.68709582 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.39069730 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.34926216 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.23671728 |
| 7 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.01267674 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.89013399 |
| 9 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.77484886 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.48785259 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.36680460 |
| 12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.08481620 |
| 13 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.61887562 |
| 14 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.23946374 |
| 15 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.21162236 |
| 16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.21131941 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.18295338 |
| 18 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.11519705 |
| 19 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.11303687 |
| 20 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.08593319 |
| 21 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.05381842 |
| 22 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.6377248 |
| 23 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.95532154 |
| 24 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.89787055 |
| 25 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.86493793 |
| 26 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.75116227 |
| 27 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.72408844 |
| 28 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.69497301 |
| 29 | SPI1_23127762_ChIP-Seq_K562_Human | 1.68621533 |
| 30 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.62706020 |
| 31 | MYB_26560356_Chip-Seq_TH2_Human | 1.59774724 |
| 32 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.58167117 |
| 33 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.57422813 |
| 34 | GATA1_22025678_ChIP-Seq_K562_Human | 1.57093549 |
| 35 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.54752308 |
| 36 | GATA3_26560356_Chip-Seq_TH2_Human | 1.52991342 |
| 37 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.50273550 |
| 38 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.49256164 |
| 39 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47589293 |
| 40 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.47393689 |
| 41 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.46287503 |
| 42 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.43371721 |
| 43 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.42868566 |
| 44 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.42522057 |
| 45 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.41997511 |
| 46 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.41260424 |
| 47 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.39290152 |
| 48 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.35189417 |
| 49 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.34898099 |
| 50 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.34483014 |
| 51 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.31752715 |
| 52 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.31676976 |
| 53 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.31182201 |
| 54 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.30798963 |
| 55 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28668755 |
| 56 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.28602368 |
| 57 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.28441256 |
| 58 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.28441256 |
| 59 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.26470087 |
| 60 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.26222638 |
| 61 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.25830754 |
| 62 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.25220495 |
| 63 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.24974957 |
| 64 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.24921365 |
| 65 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22129170 |
| 66 | STAT3_23295773_ChIP-Seq_U87_Human | 1.21087848 |
| 67 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.20786381 |
| 68 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.17884793 |
| 69 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.17563721 |
| 70 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.16692084 |
| 71 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.15815788 |
| 72 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15545738 |
| 73 | MYB_26560356_Chip-Seq_TH1_Human | 1.15476936 |
| 74 | P300_19829295_ChIP-Seq_ESCs_Human | 1.14976818 |
| 75 | VDR_22108803_ChIP-Seq_LS180_Human | 1.14776490 |
| 76 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.14764676 |
| 77 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.14365118 |
| 78 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.13759699 |
| 79 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.12768093 |
| 80 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.12528992 |
| 81 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.11819575 |
| 82 | TP53_16413492_ChIP-PET_HCT116_Human | 1.10786308 |
| 83 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.10544925 |
| 84 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.10400448 |
| 85 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.09974642 |
| 86 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.08191380 |
| 87 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.07850701 |
| 88 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.07825554 |
| 89 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.06534495 |
| 90 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.06019890 |
| 91 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.05766601 |
| 92 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.05764270 |
| 93 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05328530 |
| 94 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.05250345 |
| 95 | TCF4_23295773_ChIP-Seq_U87_Human | 1.03314646 |
| 96 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01494840 |
| 97 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.01072562 |
| 98 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.00231923 |
| 99 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.99867133 |
| 100 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.99341891 |
| 101 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.99285021 |
| 102 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.99222124 |
| 103 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.95686840 |
| 104 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.95145361 |
| 105 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.94804465 |
| 106 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93387962 |
| 107 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.92652522 |
| 108 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.92178150 |
| 109 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.90973029 |
| 110 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.90569171 |
| 111 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.90569171 |
| 112 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89514382 |
| 113 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.89507324 |
| 114 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.88360939 |
| 115 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.87802377 |
| 116 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.87778554 |
| 117 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.87487236 |
| 118 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.87417810 |
| 119 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.87230321 |
| 120 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.86802958 |
| 121 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.86414802 |
| 122 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.86276861 |
| 123 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.84685769 |
| 124 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.84548378 |
| 125 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.80480675 |
| 126 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.77031379 |
| 127 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.76953561 |
| 128 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.74288491 |
| 129 | * AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.73796157 |
| 130 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.72533714 |
| 131 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.72533714 |
| 132 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.71136220 |
| 133 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.70797830 |
| 134 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.69659603 |
| 135 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.69238438 |
| 136 | * KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.68088458 |
| 137 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.67219618 |
| 138 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.66783702 |
| 139 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.63791233 |
| 140 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.63377302 |
| 141 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61761678 |
| 142 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.61495234 |
| 143 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.60893359 |
| 144 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.58648734 |
| 145 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.58584611 |
| 146 | GATA1_19941826_ChIP-Seq_K562_Human | 0.55568291 |
| 147 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.53861759 |
| 148 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.53473439 |
| 149 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.52634096 |
| 150 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.51977962 |
| 151 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.51636781 |
| 152 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.51597594 |
| 153 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.51498532 |
| 154 | GATA2_19941826_ChIP-Seq_K562_Human | 0.51229664 |
| 155 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.51223835 |
| 156 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.51179836 |
| 157 | AR_20517297_ChIP-Seq_VCAP_Human | 0.50322827 |
| 158 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.49575387 |
| 159 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.48963777 |
| 160 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.48896040 |
| 161 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.48779994 |
| 162 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.48667050 |
| 163 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.47683737 |
| 164 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.46587121 |
| 165 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.46290064 |
| 166 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.46077422 |
| 167 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.45163215 |
| 168 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.44523090 |
| 169 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.44494793 |
| 170 | CBP_21632823_ChIP-Seq_H3396_Human | 0.43529441 |
| 171 | * P53_21459846_ChIP-Seq_SAOS-2_Human | 0.43369894 |
| 172 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.42893729 |
| 173 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.42765452 |
| 174 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.41879637 |
| 175 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.41315536 |
| 176 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.41166560 |
| 177 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.40943566 |
| 178 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.38688389 |
| 179 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.37129988 |
| 180 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.37129577 |
| 181 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.36424720 |
| 182 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.36219949 |
| 183 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.36120083 |
| 184 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.35898534 |
| 185 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.35692665 |
| 186 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.35387053 |
| 187 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.35156419 |
| 188 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.35054903 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.04204249 |
| 2 | MP0005360_urolithiasis | 7.21012345 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.18785123 |
| 4 | MP0005365_abnormal_bile_salt | 6.03253670 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.15312372 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.85991498 |
| 7 | MP0003252_abnormal_bile_duct | 3.71511292 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.63941635 |
| 9 | MP0009840_abnormal_foam_cell | 3.42808982 |
| 10 | MP0003303_peritoneal_inflammation | 3.38750466 |
| 11 | MP0000569_abnormal_digit_pigmentation | 3.16917358 |
| 12 | MP0005083_abnormal_biliary_tract | 3.13112215 |
| 13 | MP0001835_abnormal_antigen_presentation | 3.05148771 |
| 14 | MP0003195_calcinosis | 2.79904262 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.68737348 |
| 16 | MP0005332_abnormal_amino_acid | 2.68559605 |
| 17 | MP0002132_abnormal_respiratory_system | 2.67357911 |
| 18 | MP0001800_abnormal_humoral_immune | 2.60029542 |
| 19 | MP0005671_abnormal_response_to | 2.56252712 |
| 20 | MP0001666_abnormal_nutrient_absorption | 2.46012072 |
| 21 | MP0002277_abnormal_respiratory_mucosa | 2.28021966 |
| 22 | MP0002723_abnormal_immune_serum | 2.25256390 |
| 23 | MP0005000_abnormal_immune_tolerance | 2.22058839 |
| 24 | MP0000609_abnormal_liver_physiology | 2.20803441 |
| 25 | MP0001790_abnormal_immune_system | 2.16157614 |
| 26 | MP0005387_immune_system_phenotype | 2.16157614 |
| 27 | MP0000685_abnormal_immune_system | 2.15254893 |
| 28 | MP0004019_abnormal_vitamin_homeostasis | 2.14894544 |
| 29 | MP0002118_abnormal_lipid_homeostasis | 2.14558203 |
| 30 | MP0002452_abnormal_antigen_presenting | 2.12403169 |
| 31 | MP0002420_abnormal_adaptive_immunity | 2.08467798 |
| 32 | MP0001819_abnormal_immune_cell | 2.06049323 |
| 33 | MP0002138_abnormal_hepatobiliary_system | 2.01439587 |
| 34 | MP0002148_abnormal_hypersensitivity_rea | 1.96725217 |
| 35 | MP0004381_abnormal_hair_follicle | 1.90359372 |
| 36 | MP0003183_abnormal_peptide_metabolism | 1.85178984 |
| 37 | MP0005319_abnormal_enzyme/_coenzyme | 1.83681563 |
| 38 | MP0002653_abnormal_ependyma_morphology | 1.82758459 |
| 39 | MP0003868_abnormal_feces_composition | 1.79444230 |
| 40 | MP0003172_abnormal_lysosome_physiology | 1.79073487 |
| 41 | MP0002405_respiratory_system_inflammati | 1.76542358 |
| 42 | MP0003787_abnormal_imprinting | 1.75110545 |
| 43 | MP0001533_abnormal_skeleton_physiology | 1.72027508 |
| 44 | MP0001764_abnormal_homeostasis | 1.68644592 |
| 45 | MP0005310_abnormal_salivary_gland | 1.63196052 |
| 46 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.57080437 |
| 47 | MP0005451_abnormal_body_composition | 1.56785696 |
| 48 | MP0000465_gastrointestinal_hemorrhage | 1.55360857 |
| 49 | MP0000716_abnormal_immune_system | 1.50358398 |
| 50 | MP0003011_delayed_dark_adaptation | 1.49961940 |
| 51 | MP0003646_muscle_fatigue | 1.49917928 |
| 52 | MP0009697_abnormal_copulation | 1.47466441 |
| 53 | MP0009278_abnormal_bone_marrow | 1.43286246 |
| 54 | MP0003186_abnormal_redox_activity | 1.42721875 |
| 55 | MP0008260_abnormal_autophagy | 1.42170814 |
| 56 | MP0003828_pulmonary_edema | 1.41458408 |
| 57 | MP0002398_abnormal_bone_marrow | 1.38874483 |
| 58 | MP0003656_abnormal_erythrocyte_physiolo | 1.38396201 |
| 59 | MP0003300_gastrointestinal_ulcer | 1.34618288 |
| 60 | MP0003763_abnormal_thymus_physiology | 1.32954260 |
| 61 | MP0010155_abnormal_intestine_physiology | 1.27289581 |
| 62 | MP0001545_abnormal_hematopoietic_system | 1.27216214 |
| 63 | MP0005397_hematopoietic_system_phenotyp | 1.27216214 |
| 64 | MP0000689_abnormal_spleen_morphology | 1.25232560 |
| 65 | MP0003866_abnormal_defecation | 1.24951283 |
| 66 | MP0009643_abnormal_urine_homeostasis | 1.24614520 |
| 67 | MP0000604_amyloidosis | 1.22813492 |
| 68 | MP0003705_abnormal_hypodermis_morpholog | 1.22555020 |
| 69 | MP0000598_abnormal_liver_morphology | 1.20092676 |
| 70 | MP0009764_decreased_sensitivity_to | 1.19702301 |
| 71 | MP0002254_reproductive_system_inflammat | 1.18640892 |
| 72 | MP0008004_abnormal_stomach_pH | 1.17499394 |
| 73 | MP0002722_abnormal_immune_system | 1.16160058 |
| 74 | MP0008877_abnormal_DNA_methylation | 1.16096329 |
| 75 | MP0003045_fibrosis | 1.13842986 |
| 76 | MP0005670_abnormal_white_adipose | 1.10547682 |
| 77 | MP0005075_abnormal_melanosome_morpholog | 1.10288117 |
| 78 | MP0009763_increased_sensitivity_to | 1.09101203 |
| 79 | MP0005174_abnormal_tail_pigmentation | 1.05813974 |
| 80 | MP0002429_abnormal_blood_cell | 1.05555567 |
| 81 | MP0002396_abnormal_hematopoietic_system | 1.04444299 |
| 82 | MP0005647_abnormal_sex_gland | 1.03139111 |
| 83 | MP0008469_abnormal_protein_level | 0.99688919 |
| 84 | MP0003878_abnormal_ear_physiology | 0.98356033 |
| 85 | MP0005377_hearing/vestibular/ear_phenot | 0.98356033 |
| 86 | MP0001968_abnormal_touch/_nociception | 0.98229273 |
| 87 | MP0010368_abnormal_lymphatic_system | 0.95674910 |
| 88 | MP0005636_abnormal_mineral_homeostasis | 0.91445058 |
| 89 | MP0006054_spinal_hemorrhage | 0.90133432 |
| 90 | MP0009642_abnormal_blood_homeostasis | 0.89115766 |
| 91 | MP0004484_altered_response_of | 0.89018208 |
| 92 | MP0000703_abnormal_thymus_morphology | 0.87569092 |
| 93 | MP0000015_abnormal_ear_pigmentation | 0.87475925 |
| 94 | MP0004130_abnormal_muscle_cell | 0.86794126 |
| 95 | MP0001501_abnormal_sleep_pattern | 0.86701097 |
| 96 | MP0002332_abnormal_exercise_endurance | 0.86555456 |
| 97 | MP0001851_eye_inflammation | 0.86510395 |
| 98 | MP0004947_skin_inflammation | 0.85090464 |
| 99 | MP0002876_abnormal_thyroid_physiology | 0.81890183 |
| 100 | MP0005376_homeostasis/metabolism_phenot | 0.81644731 |
| 101 | MP0005408_hypopigmentation | 0.81558751 |
| 102 | MP0002736_abnormal_nociception_after | 0.81463122 |
| 103 | MP0008057_abnormal_DNA_replication | 0.81239146 |
| 104 | MP0002971_abnormal_brown_adipose | 0.81097792 |
| 105 | MP0002078_abnormal_glucose_homeostasis | 0.80603610 |
| 106 | MP0003690_abnormal_glial_cell | 0.80110446 |
| 107 | MP0009765_abnormal_xenobiotic_induced | 0.80029285 |
| 108 | MP0001663_abnormal_digestive_system | 0.79768209 |
| 109 | MP0005334_abnormal_fat_pad | 0.76459833 |
| 110 | MP0006036_abnormal_mitochondrial_physio | 0.74270017 |
| 111 | MP0003436_decreased_susceptibility_to | 0.73912441 |
| 112 | MP0003724_increased_susceptibility_to | 0.72583287 |
| 113 | MP0000427_abnormal_hair_cycle | 0.71549679 |
| 114 | MP0005464_abnormal_platelet_physiology | 0.70710311 |
| 115 | MP0005535_abnormal_body_temperature | 0.70651008 |
| 116 | MP0003221_abnormal_cardiomyocyte_apopto | 0.70345007 |
| 117 | MP0000371_diluted_coat_color | 0.70173222 |
| 118 | MP0009333_abnormal_splenocyte_physiolog | 0.69158207 |
| 119 | MP0005084_abnormal_gallbladder_morpholo | 0.67451367 |
| 120 | MP0002166_altered_tumor_susceptibility | 0.67000089 |
| 121 | MP0001986_abnormal_taste_sensitivity | 0.66823020 |
| 122 | MP0002693_abnormal_pancreas_physiology | 0.66474682 |
| 123 | MP0005220_abnormal_exocrine_pancreas | 0.65112195 |
| 124 | MP0001661_extended_life_span | 0.64857788 |
| 125 | MP0003329_amyloid_beta_deposits | 0.64725239 |
| 126 | MP0004043_abnormal_pH_regulation | 0.64084618 |
| 127 | MP0001756_abnormal_urination | 0.63830629 |
| 128 | MP0004782_abnormal_surfactant_physiolog | 0.62022464 |
| 129 | MP0000639_abnormal_adrenal_gland | 0.61611229 |
| 130 | MP0003075_altered_response_to | 0.61093009 |
| 131 | MP0005448_abnormal_energy_balance | 0.60073157 |
| 132 | MP0005266_abnormal_metabolism | 0.59227881 |
| 133 | MP0009053_abnormal_anal_canal | 0.58051514 |
| 134 | MP0005666_abnormal_adipose_tissue | 0.56451181 |
| 135 | MP0002837_dystrophic_cardiac_calcinosis | 0.54246185 |
| 136 | MP0002136_abnormal_kidney_physiology | 0.51451903 |
| 137 | MP0005395_other_phenotype | 0.50153589 |
| 138 | MP0003638_abnormal_response/metabolism_ | 0.48123315 |
| 139 | MP0008873_increased_physiological_sensi | 0.47329687 |
| 140 | MP0009115_abnormal_fat_cell | 0.46112598 |
| 141 | MP0005167_abnormal_blood-brain_barrier | 0.45874109 |
| 142 | MP0006035_abnormal_mitochondrial_morpho | 0.45592509 |
| 143 | MP0004883_abnormal_blood_vessel | 0.45366461 |
| 144 | MP0005166_decreased_susceptibility_to | 0.44983089 |
| 145 | MP0008874_decreased_physiological_sensi | 0.44904508 |
| 146 | MP0009785_altered_susceptibility_to | 0.44891689 |
| 147 | MP0005058_abnormal_lysosome_morphology | 0.44309043 |
| 148 | MP0005164_abnormal_response_to | 0.43392355 |
| 149 | MP0000249_abnormal_blood_vessel | 0.42216746 |
| 150 | MP0001845_abnormal_inflammatory_respons | 0.41941572 |
| 151 | MP0006082_CNS_inflammation | 0.41248545 |
| 152 | MP0001853_heart_inflammation | 0.40614237 |
| 153 | MP0003953_abnormal_hormone_level | 0.40077957 |
| 154 | MP0005248_abnormal_Harderian_gland | 0.39784413 |
| 155 | MP0008872_abnormal_physiological_respon | 0.38822627 |
| 156 | MP0002928_abnormal_bile_duct | 0.37690309 |
| 157 | MP0003718_maternal_effect | 0.37492619 |
| 158 | MP0002168_other_aberrant_phenotype | 0.36963231 |
| 159 | MP0002796_impaired_skin_barrier | 0.36709185 |
| 160 | MP0002970_abnormal_white_adipose | 0.36451484 |
| 161 | MP0001881_abnormal_mammary_gland | 0.35545137 |
| 162 | MP0002822_catalepsy | 0.35520297 |
| 163 | MP0001243_abnormal_dermal_layer | 0.35418950 |
| 164 | MP0002419_abnormal_innate_immunity | 0.33499743 |
| 165 | MP0000230_abnormal_systemic_arterial | 0.33049023 |
| 166 | MP0005025_abnormal_response_to | 0.31922743 |
| 167 | MP0002060_abnormal_skin_morphology | 0.30184798 |
| 168 | MP0009672_abnormal_birth_weight | 0.29828392 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.39461509 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.27559967 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 6.93538697 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.57087224 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.55647955 |
| 6 | Xanthomatosis (HP:0000991) | 6.33427086 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 6.24415635 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.66461862 |
| 9 | Retrobulbar optic neuritis (HP:0100654) | 5.44745882 |
| 10 | Optic neuritis (HP:0100653) | 5.44745882 |
| 11 | Myositis (HP:0100614) | 5.44177980 |
| 12 | Orchitis (HP:0100796) | 5.39326927 |
| 13 | Complement deficiency (HP:0004431) | 5.19067520 |
| 14 | Recurrent bacterial skin infections (HP:0005406) | 5.11926053 |
| 15 | Recurrent abscess formation (HP:0002722) | 4.94872068 |
| 16 | Joint hemorrhage (HP:0005261) | 4.91547004 |
| 17 | Hypolipoproteinemia (HP:0010981) | 4.86757563 |
| 18 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 4.77052685 |
| 19 | Absent/shortened dynein arms (HP:0200106) | 4.77052685 |
| 20 | Eczematoid dermatitis (HP:0000976) | 4.59704831 |
| 21 | Abnormality of the common coagulation pathway (HP:0010990) | 4.55067774 |
| 22 | Hyperammonemia (HP:0001987) | 4.54589879 |
| 23 | Epidermoid cyst (HP:0200040) | 4.54429876 |
| 24 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.48058160 |
| 25 | Stomatitis (HP:0010280) | 4.47308565 |
| 26 | Hypoalphalipoproteinemia (HP:0003233) | 4.46751466 |
| 27 | Keratoconjunctivitis sicca (HP:0001097) | 4.38721892 |
| 28 | Abnormality of methionine metabolism (HP:0010901) | 4.33969320 |
| 29 | Keratoconjunctivitis (HP:0001096) | 4.24132810 |
| 30 | Ketosis (HP:0001946) | 4.19695562 |
| 31 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.16427603 |
| 32 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.15775318 |
| 33 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.13655440 |
| 34 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.12058007 |
| 35 | Hyperglycinemia (HP:0002154) | 4.08278599 |
| 36 | Fat malabsorption (HP:0002630) | 3.84479698 |
| 37 | Abnormality of complement system (HP:0005339) | 3.83406557 |
| 38 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.81616126 |
| 39 | Hyperglycinuria (HP:0003108) | 3.81462271 |
| 40 | Hypoglycemic coma (HP:0001325) | 3.76309784 |
| 41 | Abnormality of glycine metabolism (HP:0010895) | 3.72904517 |
| 42 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.72904517 |
| 43 | Abnormal ciliary motility (HP:0012262) | 3.72322625 |
| 44 | Abnormality of the intrinsic pathway (HP:0010989) | 3.70842354 |
| 45 | Hypercholesterolemia (HP:0003124) | 3.66121072 |
| 46 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.58333399 |
| 47 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.58333399 |
| 48 | Recurrent fungal infections (HP:0002841) | 3.56526626 |
| 49 | Gastrointestinal infarctions (HP:0005244) | 3.49562370 |
| 50 | Abnormality of macrophages (HP:0004311) | 3.45851684 |
| 51 | Conjugated hyperbilirubinemia (HP:0002908) | 3.39701639 |
| 52 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.38518984 |
| 53 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.38409684 |
| 54 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.33122514 |
| 55 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.32752787 |
| 56 | Recurrent skin infections (HP:0001581) | 3.32137413 |
| 57 | Hyperbilirubinemia (HP:0002904) | 3.29978162 |
| 58 | Encephalitis (HP:0002383) | 3.18225599 |
| 59 | Mediastinal lymphadenopathy (HP:0100721) | 3.10413768 |
| 60 | Abnormality of nucleobase metabolism (HP:0010932) | 3.09364127 |
| 61 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.04849824 |
| 62 | Spontaneous abortion (HP:0005268) | 3.03600378 |
| 63 | Meningitis (HP:0001287) | 3.02956408 |
| 64 | Hepatocellular carcinoma (HP:0001402) | 3.02520402 |
| 65 | Arterial thrombosis (HP:0004420) | 3.00935197 |
| 66 | Systemic lupus erythematosus (HP:0002725) | 3.00003912 |
| 67 | Myocardial infarction (HP:0001658) | 2.95418367 |
| 68 | Abnormality of T cell number (HP:0011839) | 2.95379921 |
| 69 | Ketoacidosis (HP:0001993) | 2.93464203 |
| 70 | Abnormality of serum amino acid levels (HP:0003112) | 2.90824165 |
| 71 | T lymphocytopenia (HP:0005403) | 2.90458602 |
| 72 | Delayed CNS myelination (HP:0002188) | 2.90222571 |
| 73 | Spontaneous hematomas (HP:0007420) | 2.89069866 |
| 74 | Recurrent cutaneous fungal infections (HP:0011370) | 2.87969469 |
| 75 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.87969469 |
| 76 | Steatorrhea (HP:0002570) | 2.86587821 |
| 77 | Skin nodule (HP:0200036) | 2.86214374 |
| 78 | Obstructive lung disease (HP:0006536) | 2.85682924 |
| 79 | Chronic obstructive pulmonary disease (HP:0006510) | 2.85682924 |
| 80 | Vasculitis (HP:0002633) | 2.83146425 |
| 81 | Glomerulonephritis (HP:0000099) | 2.81085924 |
| 82 | Recurrent sinusitis (HP:0011108) | 2.77766019 |
| 83 | Hemoptysis (HP:0002105) | 2.77212376 |
| 84 | Chest pain (HP:0100749) | 2.75694922 |
| 85 | Abnormality of purine metabolism (HP:0004352) | 2.73238127 |
| 86 | Metabolic acidosis (HP:0001942) | 2.71455157 |
| 87 | Stomach cancer (HP:0012126) | 2.67448812 |
| 88 | Episodic fever (HP:0001954) | 2.66890704 |
| 89 | Hypochromic microcytic anemia (HP:0004840) | 2.66568166 |
| 90 | Anorexia (HP:0002039) | 2.64712977 |
| 91 | Amyloidosis (HP:0011034) | 2.64216670 |
| 92 | Gingivitis (HP:0000230) | 2.61549436 |
| 93 | Bronchiectasis (HP:0002110) | 2.61521926 |
| 94 | Hypochromic anemia (HP:0001931) | 2.57925350 |
| 95 | Vascular calcification (HP:0004934) | 2.57132743 |
| 96 | Acanthocytosis (HP:0001927) | 2.56853916 |
| 97 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.56281398 |
| 98 | Prolonged bleeding time (HP:0003010) | 2.54136550 |
| 99 | Lethargy (HP:0001254) | 2.54062244 |
| 100 | Keratitis (HP:0000491) | 2.53095207 |
| 101 | Gout (HP:0001997) | 2.51762019 |
| 102 | Dicarboxylic aciduria (HP:0003215) | 2.50932832 |
| 103 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.50932832 |
| 104 | Gangrene (HP:0100758) | 2.50710873 |
| 105 | Peritonitis (HP:0002586) | 2.50299753 |
| 106 | Rhinitis (HP:0012384) | 2.49632812 |
| 107 | Leukocytosis (HP:0001974) | 2.49004759 |
| 108 | Urticaria (HP:0001025) | 2.46245553 |
| 109 | Pancreatic cysts (HP:0001737) | 2.46149505 |
| 110 | Abnormal gallbladder morphology (HP:0012437) | 2.45936622 |
| 111 | Spastic diplegia (HP:0001264) | 2.43515080 |
| 112 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.43333412 |
| 113 | Gingival bleeding (HP:0000225) | 2.39601046 |
| 114 | Recurrent bronchitis (HP:0002837) | 2.39075216 |
| 115 | Mitral stenosis (HP:0001718) | 2.38136402 |
| 116 | Cholelithiasis (HP:0001081) | 2.37978870 |
| 117 | Pulmonary infiltrates (HP:0002113) | 2.37822594 |
| 118 | Irritability (HP:0000737) | 2.37069935 |
| 119 | Cerebral edema (HP:0002181) | 2.36298802 |
| 120 | Hypoglycemic seizures (HP:0002173) | 2.36278902 |
| 121 | Esophageal varix (HP:0002040) | 2.34553146 |
| 122 | Menorrhagia (HP:0000132) | 2.31191258 |
| 123 | Cholecystitis (HP:0001082) | 2.29306534 |
| 124 | Abnormal gallbladder physiology (HP:0012438) | 2.29306534 |
| 125 | Cardiovascular calcification (HP:0011915) | 2.29024782 |
| 126 | Increased IgE level (HP:0003212) | 2.27744955 |
| 127 | Decreased central vision (HP:0007663) | 2.27641237 |
| 128 | Abnormality of T cells (HP:0002843) | 2.24081114 |
| 129 | Pancreatic fibrosis (HP:0100732) | 2.23160014 |
| 130 | Attenuation of retinal blood vessels (HP:0007843) | 2.22803978 |
| 131 | Neonatal onset (HP:0003623) | 2.22022619 |
| 132 | True hermaphroditism (HP:0010459) | 2.21776410 |
| 133 | Abnormality of the pleura (HP:0002103) | 2.21499304 |
| 134 | Nasal polyposis (HP:0100582) | 2.21438642 |
| 135 | Pancreatitis (HP:0001733) | 2.18811977 |
| 136 | Bronchitis (HP:0012387) | 2.17920313 |
| 137 | Constricted visual fields (HP:0001133) | 2.16201337 |
| 138 | Epistaxis (HP:0000421) | 2.15732650 |
| 139 | Thrombophlebitis (HP:0004418) | 2.15587733 |
| 140 | Brushfield spots (HP:0001088) | 2.11227021 |
| 141 | Genetic anticipation (HP:0003743) | 2.10738692 |
| 142 | Hemorrhage of the eye (HP:0011885) | 2.10153391 |
| 143 | Vertigo (HP:0002321) | 2.09925383 |
| 144 | Congenital stationary night blindness (HP:0007642) | 2.08970011 |
| 145 | Abnormality of iron homeostasis (HP:0011031) | 2.08149385 |
| 146 | Subacute progressive viral hepatitis (HP:0006572) | 2.07814063 |
| 147 | Eosinophilia (HP:0001880) | 2.05696933 |
| 148 | Enlarged kidneys (HP:0000105) | 2.04474274 |
| 149 | Sensorimotor neuropathy (HP:0007141) | 2.03141494 |
| 150 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.02905905 |
| 151 | Abolished electroretinogram (ERG) (HP:0000550) | 2.02848375 |
| 152 | Vomiting (HP:0002013) | 2.02782303 |
| 153 | Chronic otitis media (HP:0000389) | 2.02704557 |
| 154 | Malnutrition (HP:0004395) | 2.02680579 |
| 155 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.02055631 |
| 156 | Nephritis (HP:0000123) | 2.01924544 |
| 157 | Late onset (HP:0003584) | 2.00905029 |
| 158 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.00637742 |
| 159 | Chronic sinusitis (HP:0011109) | 2.00553420 |
| 160 | Poikilocytosis (HP:0004447) | 2.00500119 |
| 161 | Generalized aminoaciduria (HP:0002909) | 1.97920226 |
| 162 | Abnormality of the gallbladder (HP:0005264) | 1.96747045 |
| 163 | Abnormality of proline metabolism (HP:0010907) | 1.96671550 |
| 164 | Hydroxyprolinuria (HP:0003080) | 1.96671550 |
| 165 | Recurrent pneumonia (HP:0006532) | 1.95981033 |
| 166 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.94567696 |
| 167 | Abnormal cartilage morphology (HP:0002763) | 1.94168397 |
| 168 | Opisthotonus (HP:0002179) | 1.89972878 |
| 169 | Hypertriglyceridemia (HP:0002155) | 1.88883332 |
| 170 | Rickets (HP:0002748) | 1.87923088 |
| 171 | Chronic bronchitis (HP:0004469) | 1.87149545 |
| 172 | Autoimmune hemolytic anemia (HP:0001890) | 1.86860405 |
| 173 | Granulocytopenia (HP:0001913) | 1.86495094 |
| 174 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.86321557 |
| 175 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.85913214 |
| 176 | Abnormality of eosinophils (HP:0001879) | 1.84076048 |
| 177 | Sepsis (HP:0100806) | 1.83711768 |
| 178 | Thyroiditis (HP:0100646) | 1.83120690 |
| 179 | Microcytic anemia (HP:0001935) | 1.81506841 |
| 180 | Elevated hepatic transaminases (HP:0002910) | 1.81402445 |
| 181 | Abnormality of T cell physiology (HP:0011840) | 1.81349727 |
| 182 | Alkalosis (HP:0001948) | 1.80886588 |
| 183 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.79938672 |
| 184 | Abnormality of the peritoneum (HP:0002585) | 1.79751556 |
| 185 | Hypophosphatemic rickets (HP:0004912) | 1.78823387 |
| 186 | Abnormality of midbrain morphology (HP:0002418) | 1.77726734 |
| 187 | Molar tooth sign on MRI (HP:0002419) | 1.77726734 |
| 188 | Abnormality of the endocardium (HP:0004306) | 1.77544204 |
| 189 | Pulmonary embolism (HP:0002204) | 1.77092295 |
| 190 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.76574068 |
| 191 | Renal cortical cysts (HP:0000803) | 1.75570883 |
| 192 | Autoimmune thrombocytopenia (HP:0001973) | 1.75386155 |
| 193 | Pustule (HP:0200039) | 1.75031999 |
| 194 | Gaze-evoked nystagmus (HP:0000640) | 1.74493188 |
| 195 | Increased purine levels (HP:0004368) | 1.73912764 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.70810443 |
| 2 | SIK1 | 4.34581651 |
| 3 | FGFR4 | 4.31478384 |
| 4 | ERN1 | 4.29483631 |
| 5 | RIPK4 | 3.79897012 |
| 6 | IRAK4 | 3.28792887 |
| 7 | MST1R | 2.73680637 |
| 8 | INSRR | 2.68952833 |
| 9 | TAOK3 | 2.63383655 |
| 10 | ERBB4 | 2.47428933 |
| 11 | PKN2 | 2.35883198 |
| 12 | TRIB3 | 2.13107575 |
| 13 | TXK | 2.12209718 |
| 14 | FES | 2.07778070 |
| 15 | TYK2 | 2.02705703 |
| 16 | MAP2K4 | 2.02575892 |
| 17 | TNK2 | 2.01372585 |
| 18 | FLT3 | 1.85814150 |
| 19 | DAPK2 | 1.83400199 |
| 20 | MAPK11 | 1.72924512 |
| 21 | ACVR1B | 1.69572726 |
| 22 | PTK2B | 1.66817549 |
| 23 | IRAK2 | 1.65961043 |
| 24 | LATS1 | 1.56269217 |
| 25 | PTK6 | 1.55493514 |
| 26 | FGR | 1.50867381 |
| 27 | SYK | 1.47907331 |
| 28 | PIK3CG | 1.46145470 |
| 29 | TBK1 | 1.44981078 |
| 30 | HCK | 1.44823045 |
| 31 | ABL2 | 1.44212853 |
| 32 | BTK | 1.43479743 |
| 33 | NEK9 | 1.41289726 |
| 34 | FRK | 1.36140743 |
| 35 | TAOK1 | 1.35846910 |
| 36 | LYN | 1.33739846 |
| 37 | FGFR2 | 1.32060834 |
| 38 | JAK2 | 1.30183264 |
| 39 | MAP3K14 | 1.29976179 |
| 40 | KDR | 1.29199002 |
| 41 | ADRBK2 | 1.26846128 |
| 42 | EPHB1 | 1.25418591 |
| 43 | JAK1 | 1.23754568 |
| 44 | CAMK1D | 1.21447846 |
| 45 | TEC | 1.20411037 |
| 46 | MAPK13 | 1.19592738 |
| 47 | YES1 | 1.16179241 |
| 48 | PRKAA2 | 1.15359817 |
| 49 | MAP2K3 | 1.14430606 |
| 50 | GRK6 | 1.10122682 |
| 51 | BMPR2 | 1.06011292 |
| 52 | MARK3 | 1.05372637 |
| 53 | MAP3K3 | 1.04152771 |
| 54 | CSK | 1.03947301 |
| 55 | MET | 1.03379551 |
| 56 | MATK | 1.02494085 |
| 57 | OXSR1 | 1.02133963 |
| 58 | EPHA3 | 0.96352895 |
| 59 | ERBB2 | 0.96087285 |
| 60 | MAP3K7 | 0.95044616 |
| 61 | MAPK4 | 0.94711773 |
| 62 | TGFBR2 | 0.93999933 |
| 63 | RIPK1 | 0.92658443 |
| 64 | WNK3 | 0.92587171 |
| 65 | MAP3K10 | 0.88844503 |
| 66 | LCK | 0.87071822 |
| 67 | NLK | 0.86317873 |
| 68 | SIK2 | 0.86262351 |
| 69 | PINK1 | 0.86163427 |
| 70 | PBK | 0.85039141 |
| 71 | PRKCZ | 0.84984158 |
| 72 | IKBKE | 0.83059576 |
| 73 | MAP3K11 | 0.82684219 |
| 74 | STK38 | 0.81398971 |
| 75 | CAMKK2 | 0.80713837 |
| 76 | CDK6 | 0.79154488 |
| 77 | NUAK1 | 0.78991241 |
| 78 | ADRBK1 | 0.78478138 |
| 79 | PRKACG | 0.77769222 |
| 80 | MAPK12 | 0.76393863 |
| 81 | IRAK3 | 0.76362216 |
| 82 | TIE1 | 0.75878210 |
| 83 | KSR2 | 0.74777452 |
| 84 | FGFR3 | 0.74326645 |
| 85 | STK11 | 0.74193389 |
| 86 | SIK3 | 0.72619966 |
| 87 | TLK1 | 0.69575022 |
| 88 | GRK7 | 0.69485337 |
| 89 | CDK19 | 0.67638788 |
| 90 | PAK3 | 0.66684340 |
| 91 | STK38L | 0.66663970 |
| 92 | PTK2 | 0.65861474 |
| 93 | GSK3A | 0.64775551 |
| 94 | CSF1R | 0.63258825 |
| 95 | MAPK15 | 0.61885147 |
| 96 | PDPK1 | 0.59215198 |
| 97 | GRK5 | 0.58523664 |
| 98 | PRKAA1 | 0.57818484 |
| 99 | MAP4K2 | 0.57479107 |
| 100 | CAMK2G | 0.57191004 |
| 101 | RAF1 | 0.55552484 |
| 102 | MAP2K6 | 0.55200435 |
| 103 | DYRK1B | 0.54149715 |
| 104 | IGF1R | 0.52947108 |
| 105 | MAP2K1 | 0.50112070 |
| 106 | CAMK1G | 0.49971771 |
| 107 | SGK3 | 0.49737760 |
| 108 | STK10 | 0.49710274 |
| 109 | GRK1 | 0.48918330 |
| 110 | MARK2 | 0.48874521 |
| 111 | HIPK2 | 0.47957200 |
| 112 | FYN | 0.47230127 |
| 113 | KSR1 | 0.46763073 |
| 114 | MAP3K13 | 0.45776899 |
| 115 | PRKCQ | 0.43611687 |
| 116 | EGFR | 0.43304415 |
| 117 | RET | 0.43224659 |
| 118 | ZAP70 | 0.42982383 |
| 119 | MAPK7 | 0.42851299 |
| 120 | PIM1 | 0.41838939 |
| 121 | DYRK3 | 0.41017876 |
| 122 | BMX | 0.40693828 |
| 123 | SGK223 | 0.40394428 |
| 124 | SGK494 | 0.40394428 |
| 125 | BLK | 0.39695616 |
| 126 | CSNK1G1 | 0.38214599 |
| 127 | CDK4 | 0.37479509 |
| 128 | MAP3K5 | 0.37073784 |
| 129 | PDK1 | 0.36728889 |
| 130 | BMPR1B | 0.36434528 |
| 131 | DYRK1A | 0.35570164 |
| 132 | CAMK4 | 0.34751659 |
| 133 | SGK1 | 0.34004619 |
| 134 | MAP3K6 | 0.32451307 |
| 135 | MAP3K1 | 0.32076574 |
| 136 | IRAK1 | 0.31890160 |
| 137 | EPHB2 | 0.31618863 |
| 138 | KIT | 0.30725624 |
| 139 | MAP4K1 | 0.29463559 |
| 140 | ABL1 | 0.27799878 |
| 141 | TAOK2 | 0.27575547 |
| 142 | MAP3K2 | 0.26661802 |
| 143 | SGK2 | 0.26426542 |
| 144 | MTOR | 0.26031522 |
| 145 | MAP2K2 | 0.25670084 |
| 146 | JAK3 | 0.25530220 |
| 147 | CHUK | 0.25287947 |
| 148 | PKN1 | 0.25188194 |
| 149 | EPHA2 | 0.24128888 |
| 150 | PRKCA | 0.24073207 |
| 151 | STK3 | 0.23901467 |
| 152 | ITK | 0.23466580 |
| 153 | IKBKB | 0.22901747 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.37259849 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.67214503 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.39770487 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.29694554 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.07502233 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.84711268 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.71524646 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.66166510 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.62296326 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.55069721 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.50445913 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.46835163 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.46206643 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.34518872 |
| 15 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.27463331 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.23368673 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.17638444 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 2.09359598 |
| 19 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.06623582 |
| 20 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.03581188 |
| 21 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.02813734 |
| 22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.02771458 |
| 23 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.01251331 |
| 24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.99808607 |
| 25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.99625905 |
| 26 | Tuberculosis_Homo sapiens_hsa05152 | 1.98867316 |
| 27 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.92691349 |
| 28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.92395942 |
| 29 | Histidine metabolism_Homo sapiens_hsa00340 | 1.90959190 |
| 30 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.87054042 |
| 31 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.84783658 |
| 32 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.84243493 |
| 33 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.74749235 |
| 34 | Allograft rejection_Homo sapiens_hsa05330 | 1.74649162 |
| 35 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.73887537 |
| 36 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.71443622 |
| 37 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.70936014 |
| 38 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.70668076 |
| 39 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.68684417 |
| 40 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.67127031 |
| 41 | Retinol metabolism_Homo sapiens_hsa00830 | 1.64509956 |
| 42 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.64210928 |
| 43 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.61354070 |
| 44 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.59877112 |
| 45 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.55764546 |
| 46 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.54700426 |
| 47 | Measles_Homo sapiens_hsa05162 | 1.53952723 |
| 48 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.53282981 |
| 49 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.51396164 |
| 50 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.51082211 |
| 51 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.49552309 |
| 52 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.49086985 |
| 53 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.48018490 |
| 54 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.47631077 |
| 55 | Bile secretion_Homo sapiens_hsa04976 | 1.44044405 |
| 56 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.42668607 |
| 57 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.40909641 |
| 58 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.37896125 |
| 59 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.35321783 |
| 60 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.34123811 |
| 61 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.33882859 |
| 62 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.28568814 |
| 63 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.27017018 |
| 64 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.24243183 |
| 65 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.21523464 |
| 66 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.20607300 |
| 67 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.20510108 |
| 68 | Influenza A_Homo sapiens_hsa05164 | 1.20212835 |
| 69 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.19839439 |
| 70 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.19499116 |
| 71 | ABC transporters_Homo sapiens_hsa02010 | 1.18626626 |
| 72 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.16402017 |
| 73 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.16221427 |
| 74 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.15868788 |
| 75 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.12733227 |
| 76 | Carbon metabolism_Homo sapiens_hsa01200 | 1.12574653 |
| 77 | Platelet activation_Homo sapiens_hsa04611 | 1.05513617 |
| 78 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.01347241 |
| 79 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.00457007 |
| 80 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.98536558 |
| 81 | Phagosome_Homo sapiens_hsa04145 | 0.97685332 |
| 82 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.94910193 |
| 83 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.93879987 |
| 84 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.93682706 |
| 85 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.93640373 |
| 86 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.92903091 |
| 87 | Sulfur relay system_Homo sapiens_hsa04122 | 0.92694778 |
| 88 | Asthma_Homo sapiens_hsa05310 | 0.90501832 |
| 89 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.89467976 |
| 90 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.88328684 |
| 91 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.87554330 |
| 92 | Olfactory transduction_Homo sapiens_hsa04740 | 0.86951365 |
| 93 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.86887017 |
| 94 | Phototransduction_Homo sapiens_hsa04744 | 0.86628563 |
| 95 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.86211240 |
| 96 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.84919599 |
| 97 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.84576389 |
| 98 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.82738541 |
| 99 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.80381649 |
| 100 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.77582123 |
| 101 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.77578876 |
| 102 | Lysine degradation_Homo sapiens_hsa00310 | 0.75802057 |
| 103 | Hepatitis B_Homo sapiens_hsa05161 | 0.74812925 |
| 104 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.71970309 |
| 105 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70707461 |
| 106 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.70510430 |
| 107 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.70148000 |
| 108 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.68814814 |
| 109 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.68421076 |
| 110 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.67472201 |
| 111 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.66519186 |
| 112 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.66362575 |
| 113 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.65809071 |
| 114 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.65320096 |
| 115 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.65083810 |
| 116 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.64845472 |
| 117 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.64378506 |
| 118 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.63942986 |
| 119 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.63601672 |
| 120 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.63398829 |
| 121 | Morphine addiction_Homo sapiens_hsa05032 | 0.61959689 |
| 122 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.58757797 |
| 123 | Viral myocarditis_Homo sapiens_hsa05416 | 0.58322960 |
| 124 | Salmonella infection_Homo sapiens_hsa05132 | 0.52711119 |
| 125 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51746253 |
| 126 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.47545262 |
| 127 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.47227548 |
| 128 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.47014687 |
| 129 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.46508127 |
| 130 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.45786232 |
| 131 | Apoptosis_Homo sapiens_hsa04210 | 0.44221620 |
| 132 | Metabolic pathways_Homo sapiens_hsa01100 | 0.43573900 |
| 133 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41483900 |
| 134 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.41308396 |
| 135 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.39681469 |
| 136 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.39542638 |
| 137 | Long-term depression_Homo sapiens_hsa04730 | 0.38729396 |
| 138 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.35683412 |
| 139 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.30873052 |
| 140 | Prion diseases_Homo sapiens_hsa05020 | 0.30294826 |
| 141 | Insulin resistance_Homo sapiens_hsa04931 | 0.28002373 |
| 142 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.25199632 |
| 143 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.24915309 |
| 144 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24264458 |
| 145 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.23346073 |
| 146 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16040512 |
| 147 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.15517427 |
| 148 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.09400780 |
| 149 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.05711902 |
| 150 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2146182 |
| 151 | Legionellosis_Homo sapiens_hsa05134 | -0.2009909 |
| 152 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.1980786 |
| 153 | Amoebiasis_Homo sapiens_hsa05146 | -0.1929794 |
| 154 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1839689 |
| 155 | Lysosome_Homo sapiens_hsa04142 | -0.1825227 |
| 156 | Malaria_Homo sapiens_hsa05144 | -0.1788738 |
| 157 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1707267 |
| 158 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1695367 |
| 159 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1664640 |
| 160 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1533750 |
| 161 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1512021 |
| 162 | Hepatitis C_Homo sapiens_hsa05160 | -0.1322957 |
| 163 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1192480 |
| 164 | Pertussis_Homo sapiens_hsa05133 | -0.0990025 |
| 165 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0892799 |
| 166 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0838878 |
| 167 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0815406 |
| 168 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0645638 |
| 169 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0451282 |
| 170 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0210853 |

